Axalta Coating Systems Ltd. Profile Avatar - Palmy Investing

Axalta Coating Systems Ltd.

Axalta Coating Systems Ltd., through its subsidiaries, manufactures, markets, and distributes high-performance coatings systems in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It operates through two segments, Perf…
Chemicals - Specialty
US, Glen Mills [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 17% Weak
Per Share Metrics 0% Bad
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 24.05 54.93 44.28
Graham Fair Price -25.10 5.74 7.66
PEG -100.00 -1.02 0.00
Price/Book 1.14 4.38 4.33
Price/Cash Flow 2040.34 631.53 29.51
Prices/Earnings 80.71 46.21 25.57
Price/Sales 1.62 5.86 5.76
Price/FCF 2040.34 631.53 29.51
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 1.56 0.33 0.33
Operating Margin -24.75 0.09 0.12
ROA -42.46 < 0.005 0.01
ROE 0.04 0.02 -44.03
ROIC 0.02 0.02 -29.98
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.03 < 0.005 -1408.62
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -0.01 -0.25 -1752.21
EPS QOQ 0.00 -0.45 -100.00
FCF QOQ 0.42 -0.95 127.89
Revenue QOQ < 0.005 < 0.005 71.54
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 76.33 78.14 2.37
Days Sales Outstanding (DSO) 87.41 86.38 -1.17
Inventory Turnover 1.18 1.15 -2.31
Debt/Capitalization 0.67 0.66 -1.10
Quick Ratio 1.37 1.40 2.02
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 7.85 7.86 0.12
Cash 3.18 2.83 -10.96
Capex -0.15 -0.10 32.58
Free Cash Flow 1.15 0.05 -95.27
Revenue 5.89 5.87 -0.34
Naive Interpretation member
05 - Per Share Metrics · Bad
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.98 2.07 4.84
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 12.18 14.83 21.81
Naive Interpretation Member
06 - Financial Health · Bad
End of AXTA's Analysis
CIK: 1616862 CUSIP: G0750C108 ISIN: BMG0750C1082 LEI: - UEI: -
Secondary Listings
AXTA has no secondary listings inside our databases.